NorthWest Biotherapeutics Inc (NWBO)

[dr_lowenstein]

so what, did Pazdur say they demanded a crossover, no he did not, further there is a great deal of misunderstanding , the issue isnt that there was a crossover it is how that crossover what handled.as a reminder:

M

ore disturbingly, the sheer fact that the trial allowed crossing over while studying a treatment of unknown efficacy in a highly selected patient population implies that the treatment benefit of DCVax is at risk of being never fully understood.

All in all, this immature report does not allow a meaningful interpretation and may nourish worries that financial considerations may override legitimate interests in information for patients and treating physicians.